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INTRODUCTION
Parkinson’s disease (PD) is a
neurodegenerative disorder caused by a loss of
dopaminergic neurons in the basal ganglia that
is characterized by a number of motor deficits
(Nackaerts et. al, 2017a). Self-generated and
well-learned movements such as handwriting
are controlled by the basal ganglia (Nackaerts
et. al, 2016a). Due to the neuronal deficits PD
causes in the basal ganglia, handwriting
difficulties may emerge. These deficits
include, most commonly, micrographia or the
progressive decrease of handwriting
amplitude. PD also presents with timing
deficits, breakdown of movement, and
irregularities in handwriting (Nackaerts et. al,
2016a). As the disease progresses, these
deficits may become even more prominent.
Dopaminergic medications are traditionally
used to treat PD. However, since motor
symptoms respond equally to medication and
accommodations, motor rehabilitation and
verbal or visual cueing are often utilized in
conjunction (Nackaerts, 2017b).
Occupational therapists working with this
population have incorporated a variety of
methods into their interventions in an attempt
to facilitate greater ease and legibility in
handwriting. These interventions include finemotor hand exercise programs, practice-based
programs, and visual and auditory cueing
(Bryant, Rintala, Lai, DeBakey & Protas,
2010). Improvement in handwriting skills can
increase quality of life and independence, as
well as decrease frustration, for those with PD
MSOT Program

(Collett et al., 2017). A systematic review of
available research was completed in order to
assess the efficacy of these interventions for
both short and long-term outcomes. Eleven
studies were identified as relevant to include in
this review. The researchers recommend that
therapists working with this population utilize
the data gathered when planning handwriting
interventions.
Terminology
Parkinson’s disease: a neurodegenerative disorder
characterized by a number of motor deficits caused
by the loss of dopaminergic neurons in the basal
ganglia
Micrographia: an impairment of a fine motor skill
manifesting mainly as a progressive reduction in
amplitude during a writing task (Nackaerts et. al,
2017b)

METHODS
Identification of Relevant Studies
A protocol (see Appendix A.) was used to
identify all relevant studies. The protocol
describes search methodology including search
terms, databases, and inclusion/exclusion
criteria.
Relevant electronic databases were searched in
February 2018 and included Google Scholar,
EBSCO Host, PubMed, OT Search, OT
Seeker, and ProQuest. The search plan and
Boolean sentence was developed by two
researchers for each database. The search was
then conducted independently by two
additional reviewers. Following the electronic
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search, the reviewers manually reviewed all
studies’ titles or abstracts to determine their
relevance. A hand search was also conducted
to identify studies not catalogued in the
databases. Once the reference lists were
individually compiled, the reviewers attempted
to reach consensus in order to finalize the final
list of studies from each database that would
be included for this review. Any discrepancies
between individual lists were resolved through
discussion with a third reviewer.
Searches were limited to English language,
peer-reviewed, quantitative studies. Specific
inclusion criteria included adults over the age
of 18 with Parkinson’s disease. Intervention
terms included “handwriting”, “writing”,
“penmanship”, “agraphia”, and/or
“dysgraphia”. Neurological disorders that
resemble Parkinson’s disease were also
excluded.
Appraising Study Validity
Two reviewers independently read each article
and appraised the study’s validity using
criteria to assess the quality and level of
evidence. The quality of evidence was
measured using a modified version of the
GRADES criteria (Dijkers, 2013). The level of
evidence was assessed using an adapted
version of the criteria developed by Sackett,
Rosenberg, Muir Gray, Haynes & Richardson
(1996). Two reviewers compared their
findings for each article and settled any
discrepancies with a third-party reviewer.
Pertinent information from each article was
consolidated into the Study Description Table
(see Table 2.), which includes information on
design type, level of evidence, quality level,
population, intervention, comparisons, number
of subjects, outcomes, measurements, mean,
statistical significance and clinical
significance. If studies did not provide clinical
significance, the information was substituted
with a calculated minimally detectable
MSOT Program
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Terminology
Quality of evidence: a measure of rigor in a study’s
methodology (Crocker, Lehtonen, McDonald, Miele,
& Potvin, 2016)
Level of evidence: a measure of rigor in a study’s
design (Crocker, Lehtonen, McDonald, Miele, &
Potvin, 2016)
Clinical significance: a detectable measure of
change in a clinical setting (Potvin, 2018)
Minimally detectable change (MDC): the smallest
amount of change that can be measured (Potvin,
2018)
Minimally clinically important difference
(MCID): the smallest amount of change that has
some significance in a patient’s life. (Potvin, 2018)

difference (MDD) or the minimal clinically
important difference (MCID).

RESULTS
The database searches initially retrieved 615
articles. Eleven of these articles met the preestablished inclusion criteria. This flowchart
(see Figure 1) details the study identification
process. Level of evidence in the included
articles ranged from levels 1-3. Five of the
articles were randomized control trials (level 1
evidence) and six were quasi-experimental
study designs (level 2-3 evidence). The
methodological quality of the articles ranged
from low to high, with most of the studies
being of low quality. One article, the Collett et
al. (2017) randomized control trial (RCT), was
rated as being high quality, 9/10. The quality
of evidence table (see Table 1.) provides
further details regarding each study. The
researchers compiled the studies based on the
following primary outcomes: handwriting
speed, handwriting size (including length and
amplitude), motor skills, grip strength, and
self-perceived handwriting ability.
Five studies addressed handwriting speed and
velocity. Four of these studies were level one
Thomas Jefferson – East Falls Campus
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randomized control trials, and one study was a
level two quasi-experimental study. Only
Collett et al. (2017) had a sample size larger
than 50. Two studies were statistically
significant: Nackaerts et al. (2016b) and
Nackaerts et al. (2017a). In these studies,
handwriting amplitude training did not
increase writing velocity in those with
Parkinson’s disease. An increase in
handwriting amplitude correlates with a
decrease in handwriting speed (Nackaerts et
al., 2016b; Nackaerts et al., 2017a). Collett et
al. (2017) evaluated handwriting speed using a
handwriting intervention group and an
exercise intervention group. No improvements
in handwriting speed following the
handwriting training were noted. Ziliotto et al.
(2015) found statistically insignificant
differences in handwriting velocity between a
group receiving handwriting rehabilitation and
its comparison.
Nine of the eleven studies addressed
handwriting size as a primary outcome, with
size defined as handwriting length, area, or
amplitude. Four of these studies were level 1
RCTs. Collett et al. (2017) was the only study
with a high quality of evidence. The study
authors found increases in handwriting size
from baseline to follow-up; however, they did
not report statistical significance. One
randomized control trial, Nackaerts et al.
(2016b), found a statistically significant
impact on handwriting when using visual cues.
Heremans et al. (2017), a level 2 study, and
Bryant et al. (2010), a level 3 study, found
statistical significance from baseline to posttraining in those with Parkinson’s disease
following intensive writing training. The
remaining studies that evaluated handwriting
size as an outcome either did not find the
outcome to be statistically significant or did
not report it.
Motor skills were addressed by one study,
Nackaerts et al. (2018), a RCT (level 1
MSOT Program
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evidence) with a low quality of evidence.
According to the study, there were no
statistically significant results found between
the group receiving six weeks of handwriting
intervention and the group receiving stretching
and breathing exercises (Nackaerts et al.,
2018).
Bryant et al. (2017), a quasi-experimental
study (level 3 evidence), addressed the
outcome of grip strength. The quality of
evidence was moderate. Researchers found
that six weeks of home-based hand resistance
exercises resulted in a statistically significant
increase in grip strength as measured by a
dynamometer (Bryant et al., 2017).
Collett et al. (2017) assessed participants’ selfperception of handwriting difficulty under a
variety of circumstances. The study was of
high quality, with a high level of evidence and
a large sample size (n=109). Results indicated
that participants in the handwriting group
perceived their own handwriting difficulties to
diminish whereas the subjects in the exercise
group perceived an increase in difficulty in
handwriting. These perceived difficulties did
not align with reported improvements in
handwriting.
In addition to statistical significance, the
researchers of this systematic review also
wanted to analyze the clinical significance of
handwriting interventions for those with
Parkinson’s disease. Clinical significance was
either explicitly referenced in the included
studies or the researchers determined the
clinical significance through given or
calculated effect size. The researchers
calculated the minimal detectable difference
by halving the standard deviation for studies
that did not include an effect size. For
handwriting size, handwriting speed, and
motor skills, the researchers determined there
was low clinical significance. When evaluating
grip strength as an outcome, clinical
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significance was moderate. One outcome, selfperception of handwriting difficulty, has high
clinical significance as an outcome of
handwriting intervention. It should be noted
that six of the studies that were found to be
statistically significant did not present
evidence for clinical significance.

PRACTICE RECOMMENDATIONS
Nine studies addressed handwriting size as an
outcome with a Grade B score. The studies
with positive results ranged from level 1-3
(Dijkers, 2013) with a low quality of evidence,
a low degree of clinical significance, and a
moderate benefit to burden ratio. Three of the
nine studies examining handwriting size found
statistically significant results (Bryant et al.,
2010; Heremans et al., 2016; Nackaerts et al.,
2016b). Due to the low quality of evidence,
grade, and degree of clinical significance, the
interventions addressed in these studies are not
recommended as a primary form of evidencebased treatment. The moderate burden to
benefit ratio as well as the lack of potentially
malignant effects, however, indicates the
interventions can be applied should patients
specifically request them.
Five studies addressed writing speed or
velocity and were given a Grade B. The
studies collectively had a low quality of
evidence, a low degree of clinical significance,
and a burden that exceeded expected amounts
of benefits. Only one of the five studies found
statistically positive and significant results
(Nackaerts et al., 2016b). Based on these
findings, the interventions are not
recommended to increase handwriting speed
for patients with PD.
One level 1 study addressed motor skills as an
outcome. The study did not yield positive
results and was given a Grade B (Nackaerts et
al., 2018). The study had moderate quality of
evidence, no reported clinical significance, and
a moderate benefit to burden ratio. Based on
MSOT Program

PARKINSON’S DISEASE INTERVENTIONS
the limited results of this study, the researchers
are unable to recommend handwriting
interventions as an appropriate means for
improving motor skills.
Grip strength was measured in one study. This
level 3 study yielded positive results and was
given a Grade C (Bryant et al., 2017). The
study had moderate quality of evidence,
moderate clinical significance, and a moderate
benefit to burden ratio. Based on this study the
researchers suggest that clinicians may
consider implementing home-based hand
resistance exercises to improve grip strength.
The final outcome addressed in this review
was self-perception of handwriting
performance. This outcome was from a level 1
study that did not yield positive results and
was given a grade C (Collett et al., 2017). The
study had high quality of evidence, high
clinical significance, and a high benefit to
burden ratio. Based on this study the
researchers recommend that implementing biweekly workbook, hand exercises, and writing
activities are appropriate interventions to
improve the self-perception of handwriting
skills. However, the researchers recommend
patients be informed that this study does not
support an improvement in handwriting speed
or size.

CLINICAL IMPLICATIONS
Of the nine studies that address handwriting
size, three found statistically significant
results, two for the use of visual cues (Bryant
et al., 2010; Nackaerts et al., 2016b) and one
for the use of an intensive writing program
(Heremans et al., 2016). The clinical
implications are not strong or determinable for
these studies.
Handwriting interventions were found to be
ineffective in improving writing speed and
motor skills and only limited evidence
suggested handwriting interventions may
Thomas Jefferson – East Falls Campus
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improve grip strength or handwriting size. One
study found that an intensive handwriting
intervention resulted in positive performance
perceptions but did not provide evidence
regarding improved handwriting size or speed.
Writing interventions are not harmful, and
despite the lack of clear, beneficial outcomes,
may be used if consistent with patients’ values
and needs.

CLINICAL TIPS
Currently, there are few studies regarding
handwriting interventions for patients with PD.
Three of the five outcomes addressed in this
systematic review came from a single study.
While several studies showed weak evidence
for the use of cueing and an intensive writing
program, overall there is a lack of evidence to
support handwriting interventions for PD
patients. Nackaerts et al. (2016a) found slight
evidence regarding short term effects of visual
cueing (increased amplitude even after cues
were removed) suggesting transferability of
the intervention method. More research is
necessary to further examine the differences
between short and long-term handwriting
interventions with and without cueing.
There was no evidence that handwriting
interventions improved speed. In fact,
although Bryant et al. (2010) found the use of
parallel lines improved handwriting size, the
authors stated that these improvements came at
the cost of handwriting speed. Additionally,
Bryant et al. (2010) found that the use of grid
lines was less effective than parallel lines in
increasing handwriting size and was less
preferred by patients. Results from Collett et
al. (2017), indicate that handwriting
interventions may have a positive impact on
patient perceptions of performance. Despite
limited evidence supporting improvements in
size and speed, patients with PD may still seek
handwriting interventions. These interventions
are not associated with any known adverse
effects and tend to be low cost. Therefore,
MSOT Program
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patient preference should be considered when
planning interventions.
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Appendix A. Systematic Review Protocol

Systematic Review Team Members: Jennifer Buchanan, Wanda Rybak, Vivian Stange, Julia
Wing, Veronica Yeh
Topic: Efficacy of handwriting intervention in adults with Parkinson’s disease
PICO question
P - Parkinson’s
Disease

I - Handwriting

C - N/A

O – N/A

SEARCH STRATEGY
List of the Databases to be Search:
Databases included in SR
search

Planned the search

Will conduct the search

Person 1

Person 2

Person 1

Person 2

OT Search

Jenny

Vivian

Julia

Veronica

Google Scholar

Jenny

Wanda

Vivian

Veronica

PubMed

all

all

Julia

Jenny

OT Seeker

Julia

Veronica

Vivian

Wanda

ProQuest

Wanda

Veronica

Vivian

Julia

Academic Search Premier
(EBSCO)

Julia

Vivian

Jenny

Wanda

MSOT Program
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List of Search Terms:
PubMed

Parkinson
Disease

Parkinson
Disease

Handwriting Handwriting
,
writing,
Agraphia

OT Seeker

NA

Parkinson*

NA

ProQuest

Parkinson
Disease

N/A

Handwriting N/A
,
Agraphia

Academic
Search
Premier
(EBSCO)

Parkinson’s
Disease,
Parkinsonia
n disorders

Parkinson*

Writing,
Agraphia

Handwriting*

Handwriting,
Writing,
Dysgraphia

Note: [List here the peculiarities of each database that the person searching it should keep
in mind. For example, how are subject heading searched or how to do a manual search]
*EBSCO: You cannot simply cut and paste boolean sentence.
Step 1: Boolean statement should look like (X) AND (A OR B OR C)
Step 2: Enter first part of statement into boxes (X)
Step 3: Search
Step 4: Save and name search
Step 5: Start new search for second part of boolean (A OR B OR C)
Step 6: Search and save it
Step 7: Start new search
Step 8: Select search history
Step 9: Select box next to each and select search with AND
Step 10: Save and name
*Subject heading v keywords do not make a difference in results yielded, search all as keywords*
*Google Scholar: Under advanced search:
Step 1: In box labeled “with the exact phrase,” type Parkinson’s disease (no quotation marks).
Step 2: In box labeled “with at least one of the words,” type Handwriting writing penmanship
dysgraphia (no punctuation)
Step 3: Under “where my words occur,” select “in the title of the article”
Step 4: Conduct search. Should yield 60 results.
OT Seeker: There are no subject headings in OT Seeker. Keywords (e.g. handwriting and writing)
cannot be grouped together. The keywords “Parkinson*” and “handwriting*” were searched under the
Advanced Search function and 0 results were found. A search using the keyword “Parkinson*” was
completed and yielded 141 results. The results were manually searched by two students to locate an
article that might involve a handwriting intervention. No results were found.
ProQuest:
Step One: Go to Advanced Search
Step Two: Paste Boolean Sentence into box labeled “Subject Heading (all)”
Step Three: Run Search

MSOT Program

Thomas Jefferson – East Falls Campus

8

PRACTICE BRIEF

PARKINSON’S DISEASE INTERVENTIONS

Boolean Sentence for each database:
Database Name

Boolean Sentence

OT Search

Parkinson$ AND Writing

Google Scholar

Parkinson’s disease AND handwriting OR writing OR
penmanship OR dysgraphia (*Do not put this in the search bar;
see above instructions*)

PubMed

(Parkinson disease OR Parkinsonian Disorders) AND
(handwriting OR writing OR Agraphia)

OT Seeker

Parkinson* AND Handwriting*

ProQuest

(Parkinson Disease) AND (Handwriting OR Agraphia)

EBSCO

(Parkinson*) AND (Writing OR Dysgraphia OR Agraphia)

*OT seeker and OT search were scanned using subject heading “Parkinson” and yielded
no results
ARTICLE INCLUSION and EXCLUSION CRITERIA
Inclusion Criteria
Population

Intervention and
Comparison

Adults 18+

Any of these terms
get included:
Handwriting, writing,
agraphia, dysgraphia,
penmanship

Parkinson’s Disease

Outcome

Other

Peer reviewed
journals

English
Quantitative
studies

MSOT Program
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Exclusion Criteria
Population

Intervention and
Comparison

Outcome

Other

N/A

N/A

N/A

N/A

JUSTIFICATION: Write a brief justification for each inclusion and exclusion criteria included
in the table above.
-Adults 18+: PICO question criteria
-Peer-reviewed journals: usually results in higher quality evidence and is required by
assignment
-English: accessible to searchers
-Quantitative Studies: higher level of evidence
-Parkinson’s Disease: PICO question criteria
-Handwriting, writing, agraphia, dysgraphia, penmanship: This PICO question criteria
can be phrased in a variety of ways; those listed are all acceptable.

MSOT Program
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Figure 1. Flowchart

Number of studies identified
through database search
# identified from ProQuest: 51
# identified from Google Scholar:
104
# identified from PubMed: 292
# identified from EBSCO: 167
Total: 615

Number of studies identified
through manual search or other
sources: 1

Number of studies excluded based
on title and abstract: 581
Causes of exclusion:
Not Quantitative: 22
Not English: 5
Not Population: 344
Not Intervention: 210
Total articles remaining: 34

Number of studies after duplicates
removed: 18

Total number of studies to which
inclusion/exclusion criteria was
applied to full text article: 18

Number of studies excluded after
reading the full text: 7
Causes of exclusion:
Non-quantitative: 3
Intervention: 3
Population: 1

Number of studies included in
systematic review: 11

Total articles remaining: 11

MSOT Program
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Table 1. Quality and Level of Evidence Table
Quality Criteria
Citation

Type of design

1

2

3

4

5

6

7

8

9

10

Quality
Level

Evidence
Level

Bryant et al.
(2010)

6 = One-Group pretestposttest design

0

1

0

0

0

0

1

1

3/8, Low

Level III

Bryant et al.
(2017)

6 = One-Group pretestposttest design

0

1

0

0

1

1

0

0

3/8, Low

Level III

Collett et al.
(2017)

2 = Large (n>100)
randomized clinical trial

1

1

1

1

1

1

0

1

1

1

9/10, High

Level I

Heremans et
al. (2016)

5= Nonequivalent pretestposttest control group design

0

1

1

0

0

0

1

1

1

1

6/10,
Moderate

Level II

Nackaerts et
al. (2017a)

3= Randomized Control
Trial

0

0

1

1

0

0

0

0

0

0

2/10, Low

Level I

Nackaerts et
al. (2016a)

3 = Randomized Clinical
trial

0

0

1

1

0

0

0

1

0

0

3/10, Low

Level I

Nackaerts et
al. (2018)

3 = Randomized Clinical
trial

0

0

1

1

0

0

0

0

0

0

2/10, Low

Level I

MSOT Program

Thomas Jefferson – East Falls Campus

12

PRACTICE BRIEF

PARKINSON’S DISEASE INTERVENTIONS

Nackaerts et
al. (2016b)

5 = Nonequivalent pretestposttest control group design

0

1

1

0

0

0

0

0

0

1

3/10, Low

Level I

Nackaerts et
al. (2017b)

3 = Randomized Clinical
trial

0

0

1

1

0

1

0

1

0

0

4/10, Low

Level I

Potgieser et al.
(2015)

5 = Nonequivalent pretestposttest control group design

0

1

1

0

0

0

0

0

0

1

3/10, Low

Level II

Ziliotto et al.
(2015)

5 = Nonequivalent pretestposttest control group design

0

1

1

0

0

0

0

0

0

1

3/10, Low

Level II

Table 2. Study Description Table
Included Studies
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Study

Design Type

Level of
Evidenc
e and
Quality
Level

Population
(including
age)

Intervention(
s)

Comparison(
s)

n in each
group

Outcome(s)

Measurement
(include units;
direction of
change)

Mean (SD)

Statistical
significance

Clinical
significance

Bryant
et al.
(2010)

Quasi
experimenta
l One-group
pretest
post-test
design

Level
III, 2/8

Males, PD
&
Micrograph
ia
Age: 72.20
(8.16)

Practice
writing
words using
grid and
parallel lined
paper

Comparison
to self at
baseline

n=11

Writing
length:
Parallel line
(pre-post
practice)

PlanWheel
XLU (cm; 0∞; ↑= +)

Pre: 17.83
(3.93)
Post: 23.36
(5.82)

p=0.008

MDD*=1.965

Writing
length: Grid
line (prepost
practice)

PlanWheel
XLU (cm; 0∞; ↑= +)

Pre: 17.83
(3.93)
Post: 22.65
(4.04)

p=0.003

PlanWheel
XLU (cm; 0∞; ↑= +)

Parallel:
23.36 (5.82)
Grid: 22.65
(4.04)

p>0.05

Area
measuring
tool in Adobe
Acrobat 9 (cm
^2, 0- ∞; ↑=
+)

PD Group
Pre:
2.39(0.62)
Post:
2.98(1.38)

p=0.238

MDD*=0.31

Area
measuring
tool in Adobe

Pre:
1.42(0.49)

p=0.575

MDD*=0.245

Writing
length:
Parallel line
vs. grid line
after
practice
Bryant
et al.
(2017)

Quasi
experimenta
l pre-post
design

MSOT Program

Level
III, 4/8

8 male
subjects
with PD
and 9 male
subjects
with ET.
Average
age 65.3
(6.0)

6 weeks of
home-based
hand
resistance
exercise

Comparison
to self at
baseline

n=17

Size of
writing
(words)

Thomas Jefferson – East Falls Campus
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PRACTICE BRIEF

PARKINSON’S DISEASE INTERVENTIONS

Size of
writing
(sentence)

Grip
strength

Acrobat 9 (cm
^2, 0- ∞; ↑=
+)
Smedley
digital hand
dynamometer
(kg, 0- ∞; ↑=
+)

Post: 1.42
(n/a)
p=0.031

MDD*=3.87

p=0.282

MDD*=1.39

Pre:
34.14(7.74)
Post:
37.34(5.69)
ET Group
Pre:
2.78(1.10)
Post:
3.08(1.56)
p=0.160

MDD*=0.945

Pre:
1.89(0.76)
Post:
2.21(1.21)
p=0.091

MDD*=4.08

---

MDD*=2.6
MDD*=3.8
Cohen d=0.10
(-0.33-0.52)

Pre:
31.90(8.16)
Post:
34.08(9.46)
Collett
et al.
(2017)

RCT

Level I,
9/10

61 male
and 44
female
participants
with
idiopathic
PD
Exercise
group age:
66(9);
Handwritin
g group
age: 67(7)

MSOT Program

Both groups
had 60minute
sessions 2x/
week x 6
months;

Both groups
had 60minute
session 2x/
week x 6
months

Handwriting
intervention:
workbook,
hand
exercises, an
d writing
activities.

Exercise
intervention
: 30 minutes
of aerobic
training
followed by
30 minutes

Exercise
(n=54)

Handwritin
g Speed

Clock
(seconds, 0∞; ↑= -)

Handwriti
ng (n=51)

Thomas Jefferson – East Falls Campus

SPEED-Pre
Exercise:
18.7(5.2)
Handwriting
: 21.3(7.6)
SPEED-3mo
post:
Exercise:
19.5(0.6)
Handwriting
: 20(0.6)
SPEED-6mo
post:

---

---
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PRACTICE BRIEF

PARKINSON’S DISEASE INTERVENTIONS

of resistance
training.

Exercise:
19.6(0.7)
Handwriting
: 19.5(0.7)
SPEED12mo post:
Exercise:
18.8(0.6)
Handwriting
: 19.1(0.6)
SIZE-Pre
Exercise:
43.1(23.8)
Handwriting
: 52.3(29.4)
Handwritin
g Size

Ruler (mm^2;
0- ∞; ↑= +)

SIZE-3 mo
post
Exercise
49(2.9)
Handwriting
55.3(2.9)
SIZE-6 mo
post
Exercise:
50.5(2.6)
Handwriting
53(2.7)
SIZE-12 mo
post
Exercise:
51.3(2.9)
Handwriting
: 56.7(3)

---

---

MDD*: 11.9
MDD*:14.7
Cohen
d=0.32(-0.110.74)

---

---

---

---

MSOT Program

Thomas Jefferson – East Falls Campus
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PARKINSON’S DISEASE INTERVENTIONS

Reduction
in
amplitude
of
handwriting

Ratio of first
“the” to the
second “the”
recorded as a
percentage
(0-100, ↑= +)

REDUCTION
IN
AMPLITUDE
-Pre
Exercise:
78.4(40.7)
Handwriting
: 89.0(39.2)
REDUCTION
IN
AMPLITUDE
3 mo post:
Exercise:
66.7(5.3)
Handwriting
: 77.1(5.3)
REDUCTION
IN
AMPLITUDE
6 mo post:
Exercise:
81.2(5)
Handwriting
: 75.2(5.1)
REDUCTION
IN
AMPLITUDE
12 mo post:
Exercise:
78.9(6.1)
Handwriting
: 86.3(6.4)
SELF
REPORTED
PERCEIVED
---

MSOT Program

Thomas Jefferson – East Falls Campus

MDD*: 20.35
MDD*: 19.6
Cohen
d=0.11(-0.310.53)
---

---

---

p=0.02
Odds Ratio
(95% CI)
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PRACTICE BRIEF

PARKINSON’S DISEASE INTERVENTIONS

0.55 (0.34 to
0.91)

Selfreported
Perceived
handwriting
difficulties

Herema
ns et al.
(2016)

Quasiexperimenta
l- 2 groups
pre-post
with f/u

Level II,
6/10

24 males
with PD
P-FOG age
63.4 (8.9)
P+FOG age
64.7(8.6)

6-week
intensive
writing
training 30
minutes per
day 5 days a
week

N/A
(comparison
is between
PD with and
without FOG
post
intervention
)

n=35
+FOG
(n=16)
-FOG
(n=19)

Amplitude
between
groups at
post
Amplitude
between
groups
during
retention
tests
Amplitude
from
baseline to
posttraining in

MSOT Program

Item 2.7 on
the
Movement
Disorder
Society
(MDS)–
Unified
Parkinson’s
Disease
Rating Scale
(UPDRS), a 0–
4 scale (0:
normal: no
problems, 4:
severe: most
or all words
cannot be
read)

Customwritten
Matlab
R2011b
software (%
of target size)
(0-100, ↑= +)
Customwritten
Matlab
R2011b
software (%
of target size)
(0-100, ↑= +)

Thomas Jefferson – East Falls Campus

---

p=0.03

---

---

p<0.01

---

---

p<0.01

---
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PRACTICE BRIEF

PARKINSON’S DISEASE INTERVENTIONS

PD without
FOG
Amplitude
from
baseline to
posttraining in
PD with
FOG

Nackaert
s et al.
(2017a)

RCT

Level I,
2/10

38
participants
, righthanded
with PD

Intensive
amplitude
training

Stretch and
relaxation of
upper limbs

EXP, n=18

Stroke
Duration

Customwritten
Matlab
R2011b
software (%
of target size)
(0-100, ↑= +)

Customwritten
Matlab
R2011b
software (%
of target size)
(0-100, ↑= +)

---

p=0.04

---

(s 0- ∞, ↑=
+)

---

p=0.004
(Automatiz
ation only)
p=0.001
(Transfer
task only)

---

Control,
n=20

--Writing
Velocity

(cm/s 0- ∞, ↑= +)

--Normalized
jerk

MSOT Program

(fluency 0- ∞,
↑= +)

Thomas Jefferson – East Falls Campus

No changes
(Automatiz
ation only)
p<0.001
(Transfer
task only)
p=0.027
(Automatiz
ation only)
p=0.012
(Transfer
task only)

---

---
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PRACTICE BRIEF

Nackaert
s et al.
(2016a)

RCT

Level I,
3/10

Adults w/
and w/o PD

PARKINSON’S DISEASE INTERVENTIONS

Intensive
amplitude
training

Stretch and
relaxation
programs

n=18
n=20

Amplitude
of
handwriting
, writing
size

Mean writing
size (cm, 0∞, ↑= +)

Writing
velocity
(seconds, 0∞, ↑= +))

SOS test
(i) fluency of
letter
formation; (ii)
fluency in
connections
between
letters; (iii)
regularity of
letter height;
(iv) space
between
words; and
(v)
straightness
of the
sentences) (010, ↑= +)
Use of visual
cues (Y/N)

MSOT Program

Thomas Jefferson – East Falls Campus

Experiment
al: 2.1 (0.4)
Control: 3.0
(2.9)
Experiment
al: 364.8
(126.7)
Control:
395.7
(112.4)

Experiment
al: 3.5 (1.9)
Control: 3.4
(2)

p=0.192

MDD*=0.2

p=0.431

MDD*=63.35

p=0.813

MDD*=.95

p=0.003
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Use of target
zone(Y/N)
Nackaert
s et al.
(2018)

Nackaert
s et al.
(2016b)

RCT

Quasiexperimenta
l

Level I,
2/10

Level I,
3/10

Adults with
PD

Adults w/
and w/o PD

Six weeks of
handwriting
intervention

Visual
feedback w/
varying sizes

Stretching
and
breathing
exercises

No visual
feedback

EXP, n=13
PLB, n=14

n=15

Fine Motor
Skills

MAM-16 (064;)

55.1 (5.0)

p=0.104

MDD* = 2.5

Motor skills

MDS-UPDRSIII (0-132)

27.2 (14.1)

p=0.231

MDD*=7.05

Motor Skills

MDS-UPDRSIII UL (0-56)

13.6 (6.9)

p=0.401

MDD*=3.45

Writing
amplitude
(mm, 0- ∞,
↑= +)

0.6cm: 80%
(11%)
(w/cue), 86
% (15%)
(w/o)
1.0cm: 72%
(11%)
(w/cue),
65% (11%)
(w/o)

PD/control
(p=0.005)
healthy
(p<0.001)

MDD* w/o
cue: 6.5%
w/cue: 7.5%

Handwritin
g size and
speed
(quality)

Variability of
amplitude
(mm, 0- ∞,
↑= +)

Speed
(letters/5

MSOT Program

p<0.001

Thomas Jefferson – East Falls Campus

---

PD
(p=0.044)
Healthy
(p=0.012)

PD
(p<0.001),
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PRACTICE BRIEF

Nackaert
s et al.
(2017b)

Potgiese
r et al.
(2015)

RCT

Quasiexperimenta
l, nonequivalent

Level I,
3/10

Level II,
3/10

Adults with
and w/o PD

Adults with
and
without PD

PARKINSON’S DISEASE INTERVENTIONS

Short term
training with
continuous
visual cues
(tablet)

Withdrawal
of visual
feedback
during
writing

Intermittent
intelligent
verbal
feedback
(pen)

Visual
feedback
during
writing

n=10 PD (6
cues, 4
feedback)
n=9
healthy
controls (4
cues, 5
feedback)

PD group,
n=25;
Control
group,
n=25

Writing
amplitude
of specific
letters

Handwritin
g size

min, 0- ∞, ↑=
+)

PD
323(range:
236-439),
healthy 509
(range=465551)

Difference
between the
local minima
and maxima
of each
individual
stroke (in cm,
0- ∞, ↑= +)

No mean
reported
(No SD
reported)

Letter “e”

(t=0.450)

p=0.659

---

Letter “l”

(t=4.148)

p=0.001

---

8-like
movements

(t=1.849)

p=0.082

---

Horizontal
length of
sentence (cm;
0- ∞, ↑= +)

Control w/
feedback:
12.7(2.3)
w/o: 14(2.8)

w/
feedback:
p=0.11
w/o
feedback:
p=0.44

MDD*=1.15

PD w/
feedback:
11.5(2.7)
w/o:
13.2(2.9)

healthy
(p<0.001)

---

MDD*=0.9

MSOT Program

Thomas Jefferson – East Falls Campus
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PRACTICE BRIEF

Ziliotto
et al.
(2015)

Quasiexperimenta
l,
nonequivale
nt

MSOT Program

Level II,
3/10

Adults with
PD

PARKINSON’S DISEASE INTERVENTIONS

External
Cueing
(auditory
and visual)

No external
cueing

n=30

Graphologic
al
characterist
ics of
handwriting

Summed
horizontal
word length
without
interspacing
(cm; 0- ∞, ↑=
+)

Control w/
feedback:
9.3(1.8)
w/o:
10.2(2.1)
PD w/
feedback:
8.4(2.0)
w/o:
9.2(2.1)

Letter size (0∞, ↑= +):

w/
handwriting
rehab (HR)
12.7 (5.1)

w/
feedback:
p=0.08
w/o
feedback:
p=0.09

p=0.059

MDD*=2.55

13.0 (2.8)

p=0.23

MDD*=1.4

w/o HR
13.0 (4.8)

p=0.17

MDD*=2.4

Vertical
amplitude
(mm, ↑= +)
and
width (cm,
↑= +)

13.8 (2.7)

p=0.46

MDD*=1.35

w/ HR
3.7 (1.2)

p=0.003

MDD*=0.6

Decreasing
size of letters:
First ‘e’
amplitude
(mm, ↑= +)
Last ‘e’
amplitude
(mm, ↑= +)

3.5 (1.4)

p=0.18

MDD*=0.7

w/o HR
3.8 (1.3)

p=0.61

MDD*=0.65

3.6 (1.4)

p=1.0

MDD*=0.7

Vertical
amplitude
(mm, ↑= +)
and
width (cm,
↑= +)

Thomas Jefferson – East Falls Campus
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PRACTICE BRIEF

PARKINSON’S DISEASE INTERVENTIONS

First ‘e’
amplitude
(mm, ↑= +)
Last ‘e’
amplitude
(mm, ↑= +)
Direction of
handwriting
(number of
cases and
percentage):
Ascending
(↑= +)
Horizontal
(↑= +)
Descending
(↑= +)

Ascending
(↑= +)
Horizontal
(↑= +)
Descending
(↑= +)
Surface area
of the
signature
(cm2, ↑= +)

Superior
margin (mm,
↑= +)

MSOT Program

Thomas Jefferson – East Falls Campus

p=0.19

MDD*=0

p=0.70
p=0.19

MDD*=45
MDD*=5

p=0.15
p=0.92
p=0.97

MDD*=0
MDD*=45
MDD*=5

p=0.01

MDD*=3.3

p=1.0

MDD*=3.1

p=0.001

MDD*=3.55

w/ HR
10.7 (7.1)
w/o HR
8.8 (6.9)

p=0.46

MDD*=3.45

w/HR
5.3 (1.7)
w/o HR
6.6 (1.5)

p=0.45

MDD*=0.85

p=0.02

MDD*=0.75

p=0.22

MDD*=14.05

w/ HR
0 (0)
27 (90.0)
3 (10.0)

w/o HR
0 (0)
27 (90.0)
3 (10.0)
w/ HR
7.2 (6.6)
w/o HR
9.0 (6.2)

w/ HR
83 (28.1)
w/o HR
68.9 (28.0)
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Force exerted
(calculated w/
software, 1-7, ↑= +)

Velocity
(number of
letters/Minut
e, ↑= +)

p=0.34

MDD*=14

Key: ET= Essential Tremor, EXP = Experimental Group, FOG = Freezing of Gate, MAM-Manual Ability Measure, PD = Parkinson’s Disease, PLB = Placebo Group, MDD* is calculated
using ½ SD, --- = Data not provided, mo = months, RCT = Randomized Controlled Trial

MSOT Program

Thomas Jefferson – East Falls Campus
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